Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check8 days agoChange DetectedThe site footer now identifies the website as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check28 days agoChange DetectedRecord history shows a new revision from v3.6.6 to v3.7.0. This reflects an updated version of the record rather than changes to trial data or public-facing content.SummaryDifference0.1%

- Check50 days agoChange DetectedA new page revision, v3.6.6, was added to the study record history, and the previous revision v3.6.5 was removed from the listing.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page history now displays Revision: v3.6.5, replacing the previous v3.6.4. This reflects a software version update for the ClinicalTrials.gov interface rather than a change to study information.SummaryDifference0.1%

- Check86 days agoChange DetectedThe study record history now shows a new revision, v3.6.4, as the current version, replacing the previous v3.6.3 in the history.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.